Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis
John Ravits(University of California San Diego), Steven P. Ringel(University of Colorado Boulder), Christopher E. Henderson(Columbia University), Benjamin Rix Brooks(Royal Sussex County Hospital), Jeffrey D. Rothstein(Allen Institute for Brain Science), Leo McCluskey(University of Pennsylvania), Serge Przedborski(Columbia University), Jeffrey D. Macklis(Harvard University Press), Hiroshi Mitsumoto(Columbia University Irving Medical Center), Lauren Elman(University of Pennsylvania), Robert H. Baloh(Cedars-Sinai Medical Center), Mary Kay Floeter(Emory University), Richard J. Barohn(University of Missouri Health System), Catherine Lomen‐Hoerth(University of California, San Francisco), Stanley H. Appel(Houston Methodist), Leonard H. van den Berg(Utrecht University), John Q. Trojanowski(University of Pennsylvania)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
May 1, 2013
Cited by 172
Related Papers
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease
|Journal of Neuropathology & Experimental Neurology|1997|1.6k